Experience with a measles vaccine manufactured in India.
Indian Pediatr
;
1992 Jul; 29(7): 883-7
Artigo
em Inglês
| IMSEAR
| ID: sea-7098
ABSTRACT
Five hundred and twenty seven children between 7 months and 2 years of age were vaccinated with measles vaccine manufactured by the Serum Institute of India. The sero-conversion rate in children who had no antibodies previous to vaccination was 98.4% as tested in HI. Ninety per cent of children who had pre-vaccination measles antibodies showed a two-fold or more rise in HI antibodies. The side reactions of the vaccine were negligible.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Humanos
/
Vacina contra Sarampo
/
Pré-Escolar
/
Índia
/
Lactente
/
Vírus do Sarampo
/
Anticorpos Antivirais
País/Região como assunto:
Ásia
Idioma:
Inglês
Revista:
Indian Pediatr
Ano de publicação:
1992
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS